Old Faculty

Neal E. Dunlap, M.D.

Chairman and Professor

Chairman and Professor

Dr. Neal E. Dunlap earned his medical degree from the University of Cincinnati College of Medicine.   He completed his internship at University of Cincinnati’s University Hospital, and his residency at the University of Virginia Medical Center in Charlottesville.  His clinical focus is primarily on multidisciplinary approaches to the treatment of lung cancer, esophageal cancer, head & neck cancers and liver cancers.  His research interests include the application of new treatment technologies in treatment of lung, liver, and head & neck malignancies in order to improve outcomes and reduce side effects.  He currently has investigator initiated trials open for the re-treatment of lung cancers after previous radiation, evaluation of early radiation-induced lung injury with 4-dimensional CT and the treatment of inoperable pancreatic cancer using radiosurgery.  He is currently the institutional principal investigator for multiple national cooperative group studies through NRG/RTOG in the treatment of lung and and head & neck cancers. He is member of the American Society for Radiation Oncology (ASTRO)


Education/Training

Institution and LocationDegreeDateField of Study
Paul Scherrer Institute Center for Proton Therapy6/2009-10/2009Proton Training
University of Virginia7/2007-6/2011Residency Radiation Oncology
University of Cincinnati7/2006-6/2007Internship Internal Medicine
University of CincinnatiM.D.8/2002-6/2006Doctor of Medicine
Wake Forest UniversityB.S.8/1996–5/2001Biology

Positions and Honors

Academic AppointmentsDate
Associate Clinical Director of the Multidisciplinary Head and Neck Cancer Program12/2013-present
Professor of Radiation Oncology, Department of Radiation Oncology, University of Louisville, Louisville, KY8/2011-present
Staff physician, Western State Hospital, Staunton, VA1/2009-6/2011

Other Experience and Professional Memberships

PROFESSIONAL SOCIETIES

  • AMERICAN SOCIETY OF THERAPEUTIC RADIATION ONCOLOGY
  • RADIOLOGIC SOCIETY OF NORTH AMERICA
  • SIMON KRAMER SOCIETY
  • ALPHA OMEGA ALPHA

Honors and Awards

  • RSNA ROENTGEN RESIDENT/FELLOW RESEARCH AWARD,2011
  • CLINICAL EXCELLENCE AWARD, University of Virginia Department of Radiation Oncology, 2010
    A faculty given award for recognizing clinical excellence amongst current residents
  • UNIVERSITY OF VIRGINA DEPARTMENT OF RADIATION ONCOLOGY TRAVEL SCHOLORSHIP, September 2009.
    Provided funding to train at the Paul Scherrer Institut, Center for Protons Radiotherapy, Villagen, Switzerland
  • UNIVERSITY OF VIRGINIA HOUSESTAFF COUNCIL 2009 YOUNG SCIENTIST AWARD
    Competitive institutional GME-sponsored award based on academic achievement awarded to 12 recipients of a pool of 750 residents and fellows at UVA
  • RSNA ROENTGEN RESIDENT/FELLOW RESEARCH AWARD, 2009SIMON KRAMER SOCIETY/BEST MEDICAL INTERNATIONAL TRAVEL GRANT, August 2008
    Recognizing clinical research accepted to the ASTRO Annual Meeting 2008, Boston MA
  • CLINICAL EXCELLENCE AWARD, University of Virginia Department of Radiation Oncology, 2008
    A faculty given award for recognizing clinical excellence amongst current residents

Selected peer-reviewed publications (in chronological order).

Mezera M, Chandrasekhar M, Kloecker G, Van Berkel V, Bousamra M, Dunlap NE:Stereotactic body radiation therapy as salvage for intrathoracic recurrence after definitive stereotactic body radiation therapy for early-stage lung cancer.Journal of Solid Tumors 2014:4(2):4-13.

Bhatt A, Goodwin N, Cash E, Bhatt G, Silverman C, Spanos W, Bumpous J, Potts K, Redman R, Allison W, Dunlap NE:Impact of Transcutaneous Neuromuscular Electrical Stimulation on dysphagia in head and neck cancer patients treated with definitive chemoradiation.Accepted to Head & Neck January 2014

Parks J, Kloecker G, Woo S, Dunlap NE:Stereotactic body radiation therapy for intrathoracic recurrence in patients with previously irradiated locally advanced non-small cell lung cancer.Accepted American Journal of Clinical Oncology December 18, 2013

Shaughnessy JN, Farghaly H, Wilson L, Redman R, Potts K, Bumpous J, Silverman C, Dunlap NE.:HPV: A factor in organ preservation for locally advanced larynx & hypopharynx cancer? Am J Otolaryngol. Accepted August 2013. Epub ahead of print

Harkenrider MM, Bertke MH, Dunlap NE: Stereotactic Body Radiation Therapy forUnbiopsied Early Stage Lung Cancer -A Multi-Institutional Analysis. Am J Clin Oncol 2013 May 8. Epub ahead of print.

Lee K, Kloecker G, Pan J, Rai S, Dunlap NE:The Integration of Multimodality Care for the Treatment of Small Cell Lung Cancer in a Rural Population and its Impact on Survival. Am J Clin Oncol 2013Sept 21. Epub ahead of print

Dunlap NE, Yang W, McIntosh A, Sheng K, Benedict SH, Read PW, Larner JM: Computed Tomography-Based Anatomic Assessment Overestimates Local Tumor Recurrence In Patients With Mass-like Consolidation After Stereotactic Body Radiation Therapy (SBRT) For Early Stage Non-small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2012 Dec 1:84(5):1071-7. Epub 2012 Aug 14.

Cai J, Yue J, McLawhorn R,Yang W, Wijesooriya K, Dunlap NE, Sheng K, Yin F, and Benedict SH. Dosimetric comparison of 6 mv and 15 mv single arc rapidarc to helical tomotherapy for the treatment of pancreatic cancer. Med Dosimetry2011 Autumn;36(3):317-20

Dunlap NE, McIntosh A, Sheng K, Benedict SH, Turner AB, Shoushtari A, Sheehan J, Jones DR, Larner JM, Read PW. Helical Tomotherapy-based STAT SBRT: Dosimetric Evaluation for a Real Time SBRT Treatment Planning and Delivery Program. Med Dosimetry, 2010 Winter;35(4):312-9.

Dunlap NE,Woodford RL, Shoushtari AN, et al. Primary nasopharyngeal interdigitating dendritic cell tumor presentation and response to radiation therapy: case report and literature review. Rare Tumors. 2010;2(1):27-30.

Dunlap NE, Larner JM, Read PW, et al. Size Matters: A Comparison of T1 and T2 Peripheral Non-small Cell Lung Cancers Treated With Stereotactic Body Radiation Therapy (SBRT). JCTVS.2010 Sep;140(3):583-9.

McIntosh A, Dunlap NE, Sheng K, Geesy C, Turner B, Blackhall L, Weiss G, Lappinen E, Larner J, Read P. Helical TomoTherapy STAT-RT: Dosimetric evaluation for clinical implementation of a rapid palliation program. Med.Dosimetry. 2010 Winter;35(4):280-6.

Dunlap NE, Biedermann G, Yang W, Cai J, Sheng K, Benedict S, Kavanagh B, Larner J. Chest Wall Volume Receiving More Than 30 Gy Predicts Risk of Severe Pain and/or Rib Fracture After Lung SBRT. IntJRadiatOncolBiolPhys.2010, 76(3):796-801.

RingKL, YoungJL, DunlapNE, AndersenWA, SchneiderBF. Extended-field radiation therapy with whole pelvis radiotherapy and cisplatin chemosensitization in the treatment ofIB2-IIIB cervical carcinoma: a retrospective review. AmJObstetGynecol.2009 Apr 25.

Dunlap NE, Schwartz GG, et al., 1alpha,25-dihydroxyvitamin D(3) (calcitriol) and its analogue, 19-nor-1alpha,25(OH)(2)D(2), potentiate the effects of ionising radiation on human prostate cancer cells. Br J Cancer. 2003 Aug 18;89(4):746-53.

Research Support

Ongoing Research Support

  1. RTOG 1021 (ACOSOG Z4099) A Randomized Phase III Study of Sublobar Resection (+/-Brachytherapy) versus Stereotactic Body Radiation therapy in High risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC), 3/15/2012 –12/31/2014, Principal Investigator.
  2. A Feasibility Study Using Four-Dimensional CT Imaging to Evaluate Lung Strain in Patients Treated with External Beam Radiation Therapy for Primary Lung Cancer, 6/30/2012 –7/1/2013, Principal Investigator.
  3. RTOG-0937: Randomized Phase II Study Comparing Phrophylactic Cranial Irradiation Along to Prophylactic Cranial Irradiation and Consolidative Extra-Cranial Irradiation for Extensive Disease Small Cell Lung Cancer, 10/31/2011 –12/31/201, Principal Investigator.
  4. RTOG-0839 –Randomized Phase II Study of Pre-Operative Chemoradiotherapy +/-Panitumumab (IND #110152) Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIA, N2+) Non-Small Cell Lung Cancer, 5/1/2012 –12/31/2014, Principal Investigator.
  5. RTOG 0938 –12.0236. A Radomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer, 5/1/2012 –12/31/2014, Principal Investigator.
  6. Regional Lung Strain for Radiation Treatment Planning (R21 application), 9/1/2012 –8/31/2014, Co-Investigator.
  7. RTOG 0912 –11.0144 –A Randomized Phase II Study of Concurrent Intensity Modulated Radiation Therapy (IMRT), Paclitaxel and Pazopanib (NSC 737754)/Placebo, for the Treatment of Anaplastic Thyroid Cancer, Co-Investigator.
  8. RTOG 1016 –11.0365 –Phase III Trial of Radiotherapy Plus Cetuximab Versus Chemoradiotherapy in HPV –Associated Oropharynx Cancer, Co-Investigator.
  9. RTIG 0815 –12.0422 –A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy With or Without Short-Term Androgen Deprivation Therapy for Patients With Intermediate-Risk Prostate Cancer, Co-Investigator.
  10. RTOG 0534 –12.0423 -A Phase III Trial of Short Term Androgen Deprivation With Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SUPPORT) in Prostate Cancer Patients With a Rising PSA After Radical Prostectomy, Co-Investigator.
  11. Coulter Foundation Grant 2013 (pending application): Evaluating Radiation Injury In the Course of Radiation Treatment

Adrianna Masters, M.D. , Ph.D.

Program Director & Assistant Professor

Program Director & Assistant Professor

 


Education/Training

Institution and LocationDegreeDateField of Study
Wake Forest Baptist Medical Center2015-2019Radiation Oncology Residency Program
University of Louisville School of Medicine2014-2015Internal Medicine Preliminary Year
University of Louisville School of MedicinePh.D.2013

Doctor of Philosophy, Biochemistry and Molecular Biology

Molecular Bases of Inherited Bone Marrow Failures: Shwachman-
Diamond Syndrome and Diamond Blackfan Anemia

University of Louisville School of MedicineM.D.2006-2014Physician Scientist Training Program
Wake Forest UniversityB.S.2001-2005Chemistry

Positions and Honors

Academic AppointmentsDate
Program Director & Assistant Professor, Department of Radiation Oncology, University of Louisville, Louisville, KY8/2022 - Present
Assistant Professor, Southern Illinois School of Medicine, Springfield, IL8/2019 - 4/2022
Radiation Oncology associate physician, Springfield Clinic, Springfield, IL7/2020 - 4/2022

Radiation Oncology physician, partner track, University Radiologists, SC Springfield, IL

8/2019 - 7/2020

Other Experience and Professional Memberships

ADMINISTRATIVE & LEADERSHIP ACTIVITIES:

  • Founding Member and Senior Executive Committee for SWRO (2017 - Present)
  • Membership Committee, ACRO; Diversity and Inclusion Subcommittee Chair; Women’s Subcommittee (2017 - Present)

  • New Practitioners Committee, ACRO (2017 - Present) 

  • New Practitioners Committee, ACRO Chair (2022 - Present)

  • Board of Chancellors, ACRO (2022 - Present)

  • Department representative, Cancer Control Committee, Memorial Medical Center (2020 - 2022)

  • Research Committee, Springfield Clinic (2020 - 2022)

  • IT Committee, Springfield Clinic (2020 - 2022)

  • Breast Cancer Leadership Team, Springfield Clinic (2020 - 2022) 

  • WFU, Clinical Operations Committee, Department of Radiation Oncology (2017 - 2019)

  • American Medical Women’s Association, Louisville: Treasurer (2007 - 2008)

  • Pathology Course Reform Committee, University of Louisville SOM (2008)

PROFESSIONAL MEMBERSHIPS:
  • 2017 – Present         American Society of Clinical Oncology (ASCO)
  • 2017 – Present         American College of Radiation Oncology (ACRO)
  • 2017 – 2019             Association of Residents in Radiation Oncology (ARRO)
  • 2019 - Present         American Association for Women in Radiology (AAWR)
  • 2017 – 2019            Radiological Society of North America (RSNA)
  • 2017 – Present        Society for Women in Radiation Oncology (SWRO)
  • 2016 – Present        Radiation Research Society (RRS)
  • 2016 – Present        American College of Radiology (ACR)
  • 2015 – Present        American Society of Therapeutic Radiology and Oncology (ASTRO)
  • 2014 – 2019            American Brachytherapy Society (ABS)
  • 2008 – Present       American Physician Scientists Association (APSA)
  • 2005 – Present       American Medical Women’s Association (AMWA)

Honors and Awards
  • Recognized as top 10% of providers within specialty for overall patient satisfaction scores, Press-Ganey, Springfield Clinic, 2022

  • MD/PhD Physician-Scientist Training Program University of Louisville, One of two fully funded students. University of Louisville School of Medicine, 2006-2014

  • Physician/Scientist Award: Biochemistry and Molecular Biology, University of Louisville School of Medicine, 2014
  • Dr. Norvin Green Memorial Prize (Best Thesis), University of Louisville, 2014
  • Medical Student Travel Grant: American Brachytherapy Society Meeting, University of Louisville, 2014
  • George F. Hankins, Zachary T. Smith, William K. Stamey, and Robert C. Byrd Scholarships, Wake Forest University, 2001-2005

Selected peer-reviewed publications

1. Dover L, Hentz C, Khan J, Lee A, Masters A, Doke K, Goodman C. Implications of Medical Board Certification Practices on Family Planning and Professional Trajectory for Early Career Female Radiation Oncologists. Pract Radiat Once. 2022 Mar-Apr; 12(2):95-102.

2. Su J, Song Q, Qasem S, O’Neill S, Lee J, Furdui CM, Pasche B, Metheny-Barlow L, Masters AH, Lo HW, Xing F, Watabe K, Miller LD, Tatter SB, Laxton AW, Whitlow CT, Chan MD, Soike MH, Ruiz J. Multi-Omic Analysis of Brain Metastasis Outcomes Following Craniotomy. Front Oncol. 2021Apr 6; 10:615472.

3. Lecompte MC, Hughes RT, Farris M, Masters A, Soike MH, Lanier C, Glenn C, Cramer CK, Watabe K, Su J, Ruiz J, Whitlow CT, Wang G, Laxton AW, Tatter SB, Chan MD. Impact of Brain metastasis velocity on neurologic death for brain metastasis patients experiencing distant brain failure are initial stereotactic radio surgery. J Neurooncol. 2020 Jan; 146(2):285-292.

4. Helis CA, Hughes RT Glenn CW, Lanier CM, Masters AH, Dohm A, Ahmed T, Ruiz J, Triozzi P, Gondal H, Cramer CK, Tatter SB, Laxton AW, Xing F, Lo HW, Watabe K, Wang G, Whitlow CT, Chan MD. Predictors of Adverse Radiation Effect in Brain Metastasis Patients Treated with Stereotactic Radiosurgery and Immune Checkpoint Inhibitor Therapy. Int J Radiat Oncol Viol Phys. 202 Sep 1; 108(1):295-303.

5. McTyre E, Ayala-Peacock D, Soike M, Hepel J, Page B, Shen C, Kleinberg L, Contessa J, Corso C, Chiang V, Henson A, Cramer C, Ruiz J, Pasche B, Watabe K, D’Agostino R, Su J, Laxton A, Tatter S, Fiveash J, Ahluwalia M, Kotecha R, Chao S, Braunstein S, Attia A, Chung C, Chan M. Multi-Institutional Validation of Brain Metastasis Velocity, a Recently Defined Predictor of Outcomes Following Stereotactic Radiosurgery. Radiother Oncol. 2020 Jan;142:168-174. doi: 10.1016/j.radonc.2019.08.011.

6. Masters AH, Hughes R, Strowd L, Lamar Z, Winkfield KM. Efficacy of Very-low Dose Radiotherapy for Refractory Mycosis Fungoides of the Face. JAAD Case Rep. 2019 Apr 5;5(4):348-351. doi: 10.1016/j.jdcr.2019.01.027

7. Albert A, Knoll M, Doke K, Masters AH, Lee A, Dover L, Hentz C, Puckett L, Goodman C, Osborn V, Barry P, Jagsi R. #WomenWhoCurie: Leveraging Social Media to Promote Women in Radiation Oncology. Adv Radiat Oncol. 2019 Jan 29;4(2):218-225. doi: 10.1016. j.adro.2019.01.003

8. Hughes RT, Masters AH, McTyre ER, Farris MK, Chung C, Page BR, Kleinberg LR, Hepel J, Contessa JN, Chiang V, Ruiz J, Watabe K, Su J, Fiveash JB, Braunstein S, Chao S, Attia A, Ayala-Peacock DN, Chan MD. Initial SRS for Patients with 5 to 15 brain Metastases. Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1091-1098. doi: 10.1016/j.ijrobp.2019.03.052.

9. Hughes R, Soike M, Prajapati S, Lin A, Ververs J, Masters AH, Helis C, Blackstock A, Farris M. Stereotactic body radiotherapy for an isolated splenic metastasis from ovarian carcinoma. J Radiosurg SBRT 2019;6 (2): 161-163

10. Lanier C, Hughes R, Ahmed T, Lecompte M, Masters A, Petty W, Ruiz J, Triozzi P, Su J, O’Neil S, Watabe K, Cramer CK, Laxton A, Tatter S, Wang G, Whitlow C, Chan MD. Immunotherapy is associated with improved survival and decreased neurologic death after SRS for brain metastases from lung and melanoma primaries. Neurooncol Pract. 2019 Sep; 6(5);402-409.

11. Farris MK, Wheless WH, Hughes RT, Soike MH, Masters AH, Helis CA, Chan MD, Cramer CK, Ruiz J, Lycan T, Petty WJ, Ahmed T, Leyrer CM, Blackstock AW. Limited-Stage Small Cell Lung Cancer: Is Prophylactic Cranial Irradiation Necessary? Practical Radiat Oncol. 2019 Nov;9(6):e599-e607

12. Osborn VW, Doke K, Griffith KA, Jones R, Lee A, Maquilan G, Masters AH, Albert AA, Dover LL, Puckett LL, Hentz C, Kahn JM, Colbert LE, Barry PN, Jagsi R. A Survey Study of Female Radiation Oncology Residents' Experiences to Inform Change. Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):999-1008. doi: 10.1016/j.ijrobp.2019.05.013. Epub 2019 May 17.

13. LeCompte M, McTyre E, Strowd R, Lanier C, Soike M, Hughes R, Masters A, Cramer C, Farris M, Ruiz J, Watabe K, Laxton A, Tatter S, Winkfield K, Chan M. Impact of Diabetes Mellitus on Outcomes in Patients with Brain Metastasis Treated with Stereotactic Radiosurgery. J Radiosurg SBRT. 2018;5(4):285-291.

14. McTyre E, Ayala-Peacock D, Contessa J, Corso C, Chiang V, Chung C, Fiveash J, Ahluwalia M, Kotecha R, Chao S, Attia A, Henson A, Hepel J, Braunstein S, Chan M. Multi-Institutional Competing Risk Analysis of Distant Brain Failure and Salvage Patterns after Upfront Radiosurgery without Whole Brain Radiotherapy for Brain Metastases. Ann Oncol. 2018 Feb 1; 29(2):497-503. doi: 10.1093/annonc/mdx740.

15. Osborn V, Lee A, Maquilan G, Dover L, Masters A, Puckett L, Albert A, Hentz C, Doke K, Barry P. Society for Women in Radiation Oncology: Residents’ perspectives on #MeToo and the founding of SWRO. Applied Radiation Oncology. March 2018.

16. LeCompte MC, McTyre E, Henson A, Farris M, Okoukoni C, Cramer CK, Triozzi P, Ruiz J, Watabe K, Lo HW, Munley MT, Laxton AW, Tatter SB, Zhou X, Chan M. Survival and Failure Outcomes Predicted by Brain Metastasis Volumetric Kinetics in Melanoma Patients Following Upfront Treatment with Stereotactic Radiosurgery Alone. Cureus. 2017 Dec 11; 9(12):e1934. doi: 10.7759/cureus.1934

17. Dohm A, McTyre ER, Okoukoni C, Henson A, Cramer CK, LeCompte MC, Ruiz J, Munley MT, Qasem S, Lo HW, Xing F, Watabe K, Laxton AW, Tatter SB, Chan MD. Staged Stereotactic Radiosurgery for Large Brain Metastases: Local Control and Clinical Outcomes of a One-Two Punch Technique. Neurosurgery. 2017 Jul 7 doi: 10.1093/neuros/nyx355.

18. Barry PN, Henson AL, Goodwin N, Cash E, Mezera M, Wilson L, Redman R, Perez C, Bumpous J, Potts K, Silverman C, Dunlap N. Factors predicting suitability of organ preservation with radiation therapy in laryngeal and hypopharyngeal cancer. J of Solid Tumors. 2014 Dec 4; 4(4):9-17. doi: 10.5430/jst.v4n4p9

19. Farrar JE, Quarello P, Fisher R, O'Brien KA, Aspesi A, Parrella S, Henson AL, Seidel NE, Atsidaftos E, Prakash S, Bari S, Garelli E, Arceci RJ, Dianzani I, Ramenghi U, Vlachos A, Lipton JM, Bodine DM, Ellis SR. Exploiting pre-rRNA processing in Diamond Blackfan anemia gene discovery and diagnosis. Am J Hematol. 2014 Oct;89(10):985-91.

20. Singh SA, Goldberg TA, Henson AL, Husain-Krautter S, Nihrane A, Blanc L, Ellis SR, Lipton JM, Liu JM. p53-Independent cell cycle and erythroid differentiation defects in murine embryonic stem cells haploinsufficient for Diamond Blackfan anemia-proteins: RPS19 versus RPL5. PLoS One. 2014 Feb 18;9(2)

21. Henson A, Moore J, Alard P, Wattenberg M, Liu J, Ellis S. Mitochondrial function is impaired in yeast and human cellular models of Shwachman Diamond syndrome, Biochem. Biophys. Res. Commun. 2013 Jul 19;437(1):29-34.

22. Henson A, Sezgin G, Singh S, Nihrane A, Singh S, Wattenberg M, Alard P, Ellis S, Liu J. Impaired Growth, Hematopoietic Colony Formation, and Ribosome Maturation in Human Cells Depleted of Shwachman-Diamond Syndrome Protein SBDS. Pediatr Blood Cancer. 2012 Sep 19. Feb;60(2):281-6

23. Jaako P, Flygare J, Olsson K, Quere R, Ehinger M, Henson A, Ellis S, Schambach A, Baum C, Richter J, Larsson J, Bryder D, Karlsson S. Mice with ribosomal protein S19 deficiency develop bone marrow failure and symptoms like patients with Diamond- Blackfan anemia. Blood. 2011 Dec 1;118(23):6087-96.

24. Henson AL, Ellis SR. Finding a diamond in the (mouse is) rough. Blood. 2010 Oct 14; 116(15): 2623-5.

25. Donninger H, Allen N, Henson A, Pogue J, Williams A, Gordon L, Kassler S, Dunwell T, Latif F, Clark GJ. Salvador protein is a tumor suppressor effector of RASSF1A with hippo pathway-independent functions. J Biol Chem. 2011 May 27;286(21): 18483-91.

26. Thomas LR, Henson A, Reed JC, Salsbury FR, Thorburn A. Direct binding of Fas- associated death domain (FADD) to the tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 is regulated by the death effector domain of FADD. J Biol Chem. 2004 Jul 30;279(31):32780-5.

Shiao Y. Woo, M.D., M.B.B.S., F.A.C.R.

Professor

Shiao Y. Woo, M.D., Chairman

Professor

Dr. Shiao Woo moved from M.D. Anderson Cancer Center in Houston to the University of Louisville to be the Professor and Chairman of the Department of Radiation Oncology in 2010.  He completed his residency in radiation oncology at Stanford University Medical Center.   Under his leadership the  department has acquired some of the most advanced technologies for treatment of patients and research.  In 2011 the department received full accreditation by the American College of Radiology (ACR), the highest national accreditation. The accreditation was renewed in 2014 and 2017.  The clinical research program has been significantly expanded and the department attained full membership in the national cooperative group, NRG.  There is ongoing inter-departmental collaboration with biomedical engineering researchers and cancer research scientists in several  translational research projects.

Dr. Woo is an internationally recognized authority in the treatment of brain and spinal cord tumors in adults and children. He has served on the Executive Committee of the International Pediatric Radiation Oncology Society (PROS). He is the immediate past –President of the M.D. Anderson Gilbert H. Fletcher Society, and an immediate post Council Member of the National Council of Radiation Protection and Measurement.  He is a member of the American Society for Radiation Oncology (ASTRO).  He has over 200 publications including book chapters.  Dr. Woo has been recognized for several years in “Best Doctors in America”.  Dr. Woo’s clinical and research interests include tumors of the blood, bone, nervous system andsoft tissue in children and adults.


Education/Training

Institution and LocationDegreeDateField of Study
Stanford University Medical Center, Stanford, CA7/1985-6/1988Residency in Radiation Therapy
Vincent T. Lombardi Cancer Center, Washington, DC7/1978-6/1980Fellowship in Pediatric & Adolescent
Georgetown University Hospital, Washington, DC7/1976-6/1978Residency in Pediatrics
Southern General Hospital, Glasgow, Scotland, United Kingdom7/1975-6/1976Residency in Pediatrics
Johor Baru General Hospital, Johor Baru, Malaysia7/1973-6/1975Residency in Internal Medicine
Ipoh General Hospital, Ipoh, Malaysia7/1972-6/1973Clinical Internship
University of Malaya, Kuala Lumpur, MalaysiaM.B./B.S.4/1967-5/1972Medicine

Positions and Honors

Positions and EmploymentDate
Professor (Tenured) and Chairman
Department of Radiation Oncology
Norton Children’s Hospital/Norton Healthcare in Pediatric Oncology
University of Louisville School of Medicine
Louisville, KY
3/2010-Present
Professor (Tenured) and Section Chief of CNS/Pediatrics
Department of Radiation Oncology
Division of Radiation Oncology
The University of Texas M.D. Anderson Cancer Center Houston, TX
3/2004−2/2010
Professor (non-tenure)
Pediatrics Department of Pediatrics Patient Care
Baylor College of Medicine
Houston, TX
7/2002−2/2004
Professor (Tenured)
Department of Radiology
Baylor College of Medicine
Houston, TX
7/1996−2/2004
Adjunct Associate Professor
Department of Radiology
UT Heath Science Center
Houston, TX
7/1994−6/2004

Associate Professor
Department of Radiology
Baylor College of Medicine
Houston, TX

7/1992−6/1996
Assistant Professor
Department of Radiology
Baylor College of Medicine
Houston, TX
7/1991−6/1992
Assistant Professor of Radiotherapy and Pediatrics
Department of Pediatrics
The University of Texas M.D. Anderson Cancer Center
Houston, TX
8/1988−6/1991
Assistant Professor of Pediatrics
Department of Pediatrics
Tufts University School of Medicine
Boston, MA
7/1981−6/1985
Assistant Professor of Pediatrics
Department of Pediatrics
Georgetown University School of Medicine
Washington, DC
7/1980−6/1981

Other Experience and Professional Memberships

PROFESSIONAL SOCIETIES

  • American College of Radiology
  • American Radium Society
  • American Society of Clinical Oncology
  • American Society of Therapeutic Radiology and Oncology
  • Gilbert H. Fletcher Society
  • Greater Louisville Medical Society
  • National Council Radiation Protection and Measurement
  • Pediatric Radiation Oncology
  • Society Society of Chairmen of Academic Radiation Oncology Programs

Honors

  • The Gold Apple Award for Excellence in Teaching, UT M.D. Anderson Cancer Center, 1990
  • Fellow, Royal College of Physicians, 1997
  • ACGME Parker J. Palmer Courage to Teach Award, 2001
  • Fellow, American College of Radiology, 2001
  • Teacher of the Year Award, The Association of Residents in Radiation Oncology, 2001
  • 2008 Patient Golden Apple Award, M.D. Anderson Cancer Center, 2008
  • The Julie and Ben Rogers Award for Excellence in Patient Care: Finalist, 2009

Selected peer-reviewed publications (in chronological order).

Huang E, Teh BS, Strother DR, Davis QG, Chiu JK, Lu HH, Carpenter LS, Mai WY, Chintagumpala MM, South M, Grant WH, Butler EB, W oo SY. Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity. Intl J Rad Oncol Biol Phys 52(3):599-605, 3/2002.

Merchant TE, Kun LE, Krasin MJ, Jones-W allace D, Chintagumpala MM, W oo SY, Ashley D, Sexton M, Kellie SJ, Ahern V, Gajjar A. A multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma. Intl J Rad Oncol Biol Phys 57(2 Suppl):S194-5, 2003.

Lee CT, Bilton SD, Famiglietti RM, Riley BA, Mahajan A, Chang EL, Maor MH, Woo SY, Cox JD, Smith AR. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? Intl J Rad Oncol Biol Phys 63(2):362-72, 10/2005.

Pelloski CE, Lin E, Zhang L, Yung WK, Colman H, Liu JL, Woo SY, Heimberger AB, Suki D, Prados M, Chang S, Barker FG, III, Fuller GN, Aldape KD. Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma. Clin Cancer Res 12:3935-41, 7/2006.

Gajjar A, Chintagumpala M, Ashley D, Kellie S, Kun LE, Merchant T, W oo S, Wheeler G, Ahern V, Krasin MJ, Fouladi M, Broniscer A, Krance R, Hale GA, Stewart CF, Sanford RA, Fuller C, Lau C, Boyett JM, W allace D, Gilbertson RJ. Risk-adapted craniospinal radiotherapy followed by high- dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma- 96): long-term results from a prospective, multicentre trial. Lancet Oncol 7, 10/2006.

Hermanto U, Frija EK, Lii MF, Chang EL, Mahajan A, Woo SY. Intensity modulated radiotherapy (IMRT) and conventional radiotherapy for high-grade gliomas: Does IMRT increase the integral dose to normal brain? Intl J Rad Oncol Biol Phys 67(4):1135-1144, 3/2007.

Yom SS, Frija EK, Mahajan A, Chang E, Klein K, Shiu A, Ohrt J, and Woo S. Field in field technique with intrafractionally modulated junction shifts for craniospinal irradiation. Intl J Rad Oncol Biol Phys Vol. 69:1193-1198, 6/2007.

Jani N, Krull KR, Brouwers P, Chintagumpala MM, W oo SY. Neuropsychological outcome following intensity-modulated radiation therapy for pediatric medulloblastoma. Ped Blood Cancer. e-Pub 4/2008.

Merchant T, Kun LE, Krasin MJ, Wallace D, Chintagumpala MM, Woo SY, Ashley D, Sexton M, Kellie SJ, Ahern V, Gajjar A. Multi-Institution prospective trial of reduced- dose craniospinal irradiation (23.4 GY) followed by conformal posterior fossa (36 GY) and primary site irradiation (55.8 GY) and dose-intensive chemotherapy for average-risk medullablastoma. Intl J Rad Oncol Biol Phys 70:782-787, 2008.

Newhauser W D, Fontenot JD, Mahajan A, Kornguth D,Stovall M, Zheng &, Taddei PJ, Mirkovic D, Mohan, R, Cox JD, Woo S. The risk of developing a second cancer after receiving craniospinal proton irradiation. Phys Med Biol 54(8):2277­91, 4/2009, e-Pub 3/2009.

Torres M, Woo SY, Lege D, Riley BA, Zhai X, Lii M, Kornguth D, Pelloski C, Mahajan A, Chang E,. Optimal treatment planning for skull base chardoma: photon, protons and a combonation of both. Int. J. Rad Oncol Biol Phys, 7/2009. e-Pub 4/2009.

McGovern S, Aldape K, Munsell M, Mahajan A. DeMonte F, Woo SY. A comparison of WHO grades at recurrents in patients with non-skull base and skull base meningiomas. J of Neurosurg 112:925-933, 2010.

Taddei Pj, Mirkovic D. Giebeler A. Woo SY, Newhauser D. Second cancer incidence and mortality from secondary neutions as a function of sex for two patients who received craniospinal irradiation with proton radiotherapy. In Press.

Research Support

Ongoing Research Support

Completed Research Support

Craig L. Silverman, M.D.

Professor and Clinical Director

Professor and Clinical Director

Dr. Craig Silverman received his Medical Degree from Northwestern University Medical School in Chicago, Illinois and did his residency at Mallinckrodt Institute of Radiology at Washington University School of Medicine in St. Louis, Missouri.  He has worked at the Brown Cancer Center for 20 years. He’s a full Professor in the Department of Radiation Oncology for the University of Louisville and Vice Chairman for Patient Care. His main research interests are in head and neck cancer, and he serves as Co-Director for the Multidisciplinary Head and Neck Clinic. He’s involved in numerous RTOG protocols, and has co-authored/published multiple manuscripts. He has served on numerous committees for the University. Dr. Silverman is a member of the American Society of Therapeutic Radiology and Oncology (ASTRO).


Education/Training

Institution and LocationDegreeDateField of Study
Northwestern University Medical School Chicago, ILMD1978
University of Illinois – Urbana Champaign, ILBS1974

Positions and Honors

Positions and EmploymentDate
Professor
Radiation Oncology
University of Louisville School of Medicine
Louisville, KY
7/1/08-Present
Associate Professor (Clinical Services)
Radiation Oncology
University of Louisville School of Medicine
Louisville, KY
3/2004−2/2010
Lecturer (Bridge Appointment)
Radiation Oncology
University of Louisville School of Medicine
Louisville, KY
2/15/01-4/30/01
Associate Professor, Radiation Oncology
Temple University Hospital
Temple University School of Medicine
Philadelphia, PA
5/1/90-12/12/00

Other Experience and Professional Memberships

PROFESSIONAL SOCIETIES

  • American Society for Therapeutic Radiology and Oncology
  • American College of Radiology
  • International Stereotactic Radiosurgery Society

Selected peer-reviewed publications (in chronological order)

  1. Jose,BO.,Koerner,P.,Spanos,WJ.,Paris,KJ.,Silverman,CL.,Yashar,CM., Carrascosa,LA.,”Hodgkin’s lymphoma in adults—clinical features”. J Ky Med Assoc;Vol 103,(1),15-17,January 2005.
  2. Minor,G.I.,Yashar,CM,Spanos,WJ,Jose,B.O.,Silverman,CL, Carrascosa,L.A.,Farmer,M.,Paris,K.J.: “The Relationship of Radiation Pneumonitis to Treated Lung Volume in Breast Conservation Therapy; The Breast Journal, Vol 12,(1)48-52,2006.
  3. Cheerva,C.,Raj,A.,Bertolone,SJ.,Bertolone,K.,Silverman,CL: “BK Virus-associated Hemorrhagic Cystitis in Pediatric Cancer Patients Receiving High-dose Cyclophosphamide; J Pediatr Hematol Oncol, Vol 29,(9)617-621,September 2007.

Scott Silva, M.D., Ph.D.

Assistant Professor, Director of Brachytherapy

Assistant Professor, Director of Brachytherapy

 

Dr. Silva earned his bachelor’s degree at The University of Texas at Austin and then completed the M.D./Ph.D. program at the University of Kentucky. Following medical school, he completed an internship in general surgery at Vanderbilt University, in Nashville, TN and residency in Radiation Oncology at Loyola University in Chicago, IL. Upon completion of residency, he received the RSNA Roentgen Resident Award for research on brachytherapy. His clinical focus is gynecologic and GU cancers, with a specific interest in applying brachytherapy, using radioactive sources in an internal fashion, to the management of these malignancies.



Education/Training

Institution and LocationDegreeDate of CompletionField of Study
University of Texas at AustinB.S.May 2005Biochemistry
University of KentuckyPh.D.August 2011Molecular and Cellular Biology
University of Kentucky College of MedicineM.D.May 2013Doctor of Medicine
Vanderbilt University2013-2014General Surgery Internship
Loyola University2014-2018Radiation Oncology Resident
Loyola University2017-2018Radiation Oncology Chief Resident

  

Positions and Honors

Academic AppointmentsDate
Clinical Instructor, Department of Radiation Oncology, University of Louisville, Louisville, KYAug 2018 – Sep 2019
Assistant Professor, Department of Radiation Oncology, University of Louisville, Louisville, KYSep 2019 – present

 

Other Experience and Professional Memberships

PROFESSIONAL SOCIETIES

    Date
    AMERICAN SOCIETY FOR RADIATION ONCOLOGY2014 - present
    AMERICAN COLLEGE OF RADIOLOGY2014 - present
    GREATER LOUISVILLE MEDICAL SOCIETY2018 - present
    AMERICAN BRACHYTHERAPY SOCIETY2019 - present
    SOCIETY OF GYNECOLOGIC ONCOLOGY2020 - present

    AMERICAN RADIUM SOCIETY

    2021 - present

       

    Honors and Awards

    • Radiological Society of North America Trainee Research Prize, November 2017
    • Radiological Society of North America Roentgen Resident / Fellow Research Award, June 2018
    • Selected for NextGen Brachy Program through the American Brachytherapy Society, October 2020

      

    Selected Publications in Peer-Reviewed Journals

    Matthew M. Harkenrider, MD, Fiori Alite, MD, Scott R. Silva, MD, PhD, William Small, Jr., MD. Image-Based Brachytherapy for the Treatment of Cervical Cancer. International Journal of Radiation Oncology, Biology, Physics, 92 (4): 921-934, July 15, 2015.

    Kyle Stang, Scott Silva, Alec M. Block, James S. Welsh. THE INTEGRATION OF RADIATION THERAPY AND IMMUNOTHERAPY IN MELANOMA MANAGEMENT. Journal of Radiation Oncology, 5 (2): 131-142, June 2016.

    Scott R. Silva, MD, PhD and Bahman Emami, MD.  Grade 3 radiation dermatitis in a patient with presumed latent actinic lichen planus. Advances in Radiation Oncology, 1 (3): 157-160, July-September 2016.

    Scott R. Silva, MD, PhD, Murat Surucu, PhD, Jennifer Steber, CMD, Matthew M Harkenrider, MD and Mehee Choi, MD.  CLINICAL Application of a Hybrid RapidArc Radiotherapy Technique for Locally Advanced Lung Cancer. Technology in Cancer Research & Treatment, 16 (2): 224-230, April 2017.

    Alec M. Block, Scott R. Silva, James S. Welsh. LOW-DOSE TOTAL BODY IRRADIATION: AN OVERLOOKED CANCER IMMUNOTHERAPY TECHNIQUE. Journal of Radiation Oncology, 6 (2): 109-115, June 2017.

    Scott R. Silva, Anil Sethi, Vikram Prabhu, Douglas Anderson, Edward Melian.  PROGNOSTIC FACTORS AFFECTING OVERALL SURVIVAL AND LOCAL RECURRENCE IN MENINGIOMA PATIENTS TREATED WITH RADIOTHERAPY OR COMBINED RADIOTHERAPY AND SURGERY. Journal of Radiation Oncology, 7 (1): 27-35, March 2018. 

    Karina Nieto, Brendan Martin, Nghia Pham, Laura Palmere, Scott R. Silva,Abigail Winder, Margaret Liotta, Ronald K. Potkul, William Small Jr., Matthew M. Harkenrider.  DOES ADJUVANT CONCURRENT OR SEQUENTIAL CHEMOTHERAPY INCREASE THE RADIATION-RELATED TOXICITY OF VAGINAL BRACHYTHERAPY FOR ENDOMETRIAL CANCER PATIENTS? Brachytherapy, 17 (6): 929-934, November-December 2018.

    Aman Chauhan, Zainab Farooqui, Scott R. Silva, LeAundra Murray, Kurt B Hodges, Qian Yu, Zin W. Myint, Arumugam K. Raajesekar, Heidi Weiss, B. Mark Evers, Susanne Arnold, Lowell Anthony.  Integrating a 92-Gene Expression Assay in the Management of Neuroendocrine Tumors of Unknown Primary. Asian Pacific Journal of Cancer Prevention, 20 (1): 113-116, January 25, 2019.

    Scott R. Silva, Adam Gliniewicz, Brendan Martin, Vikram C. Prabhu, Anand V. Germanwala, Edward Melian, G. Alex Jones, Abhishek A. Solanki.  OLIGOMETASTATIC DISEASE STATE IS ASSOCIATED WITH IMPROVED LOCAL CONTROL IN PATIENT UNDERGOING 3 OR 5 FRACTION SPINE STEREOTACTIC BODY RADIOTHERAPY. World Neurosurgery, 122: e342-e348, February 2019.

    Scott R. Silva, MD, PhD, Brendan Martin, PhD, Mehee Choi, MD, Bahman Emami, MD, Newton Hurst, MD, PhD.  A NATIONAL CANCER DATABASE ANALYSIS OF THE EFFECT OF BRACHYTHERAPY ON OVERALL SURVIVAL IN PATIENTS WITH BASE OF TONGUE CANCER. Head & Neck, 41 (5): 1184-1192, May 2019.

    Scott R. Silva, Jeremy T. Gaskins, Matthew R. Nichols, Daniel S. Metzinger, Sarah L. Todd, Harriet B. Eldredge-Hindy.  CERVICAL CANCER INCIDENCE AND MORTALITY RATES IN KENTUCKY.  Gynecologic Oncology, 158 (2): 446-451, August 2020.

    Leonid B. Reshko, Jeremy T. Gaskins, Daniel S. Metzinger, Sarah L. Todd, Harriet B. Eldredge-Hindy, Scott R. Silva.  THE IMPACT OF BRACHYTHERAPY BOOST AND RADIOTHERAPY TREATMENT DURATION ON SURVIVAL IN VAGINAL CANCER PATIENTS TREATED WITH DEFINITIVE CHEMORADIATION.  Brachytherapy, 20 (1): 75-84, January-February 2021.

    Leonid B. Reshko, Jeremy T. Gaskins, Sara Dryden, Daniel S. Metzinger, Sarah L. Todd, Harriet B. Eldredge-Hindy, Scott R. Silva.  The Role of Adjuvant Chemotherapy in FIGO Stage IB Grade 3 Endometrial Endometrioid Adenocarcinoma patients Treated with Surgery and Postoperative Radiotherapy.  International Journal ofGynecological Cancer, 31 (5): 694-701, May 2021.

    Garrett Lee Jensen, Parul N. Barry, Harriet Eldredge-Hindy, Scott R. Silva, Sarah Todd, Kendall Hammonds, Daniel S Metzinger, Moataz El-Ghamry.  VAGINAL CUFF BRACHYTHERAPY: DO WE NEED TO TREAT MORE THAN A TWO-CENTIMETER ACTIVE LENGTH?  Journal of ContemporaryBrachytherapy, 13 (3): 294-301, May 2021.

    Matthew R. Nichols, Jeremy T. Gaskins, Daniel S. Metzinger, Sarah L. Todd, Harriet B. Eldredge-Hindy, Scott R. Silva.  TRENDS IN INCIDENCE AND MORTALITY RATES OF UTERINE CANCER IN KENTUCKY.  Southern Medical Journal, 114 (10): 630-635, October 2021.

    Leonid B. Reshko, Jeremy T. Gaskins, Abbas Rattani, Alyssa A. Farley, Grant W. McKenzie, Scott R. Silva. PATTERNS OF CARE AND OUTCOMES OF RADIOTHERAPY OR HORMONE THERAPY IN PATIENTS WITH MEDICALLY INOPERABLE ENDOMETRIAL ADENOCARCINOMA. Gynecologic Oncology, 163 (3): 517-523, December 2021.

    Sara M. Dryden, Leonid B. Reshko, Jeremy T. Gaskins, Scott R. Silva. VERRUCOUS CARCINOMA OF THE VULVA: PATTERNS OF CARE AND TREATMENT OUTCOMES. Cancer Reports, 5 (10): e21591, October 2022.

    Alden Klarer, M.D., Ph.D.

    Assistant Professor

    AldenAssistant Professor

    Dr. Klarer is a graduate of the University of Louisville School of Medicine MD/PhD Program. She completed her Ph.D. within the Department of Biochemistry and Molecular Biology under the direction of Dr. Steven Ellis and Dr. Sucheta Telang. Her dissertation was titled "6-Phosphofructo-2-Kinase Inhibition Induces Autophagy as a Survival Mechanism". Dr. Klarer completed both her internal medicine internship and residency in radiation oncology at the University of Louisville. She is an Assistant Professor in the Department of Radiation Oncology at the University of Louisville School of Medicine. She specializes in the treatment of breast malignancies and is involved in a number of investigator-initiated and cooperative group clinical trials. Her treatment expertise and clinical interests includes intensity modulated radiation therapy, cardiac-sparing radiation therapy, stereotactic body radiotherapy, and radiobiology.

    Aaron C. Spalding, M.D., Ph.D.

    Adjunct Professor, Executive Medical Director, Norton Cancer Institute

     Adjunct Professor, Executive Medical Director, Norton Cancer Institute

    Dr. Spalding completed his undergraduate degree at the University of Michigan. He earned a doctorate in pharmacology during medical school at the University of Colorado. His post-doctoral fellowship, during his residency at the University of Michigan, focused on combining experimental cancer therapies with radiation. Dr. Spalding completed a pediatric radiation oncology fellowship at St. Jude Children's Research Hospital. He provides multidisciplinary radiation treatment for children and adults, and adds research expertise to Norton Cancer Institute's clinical trials program. Dr. Spalding joined Norton Cancer Institute in 2009. He is an adjunct faculty member to the University of Louisville School of Medicine Department of Radiation Oncology. 

    Megan Blackburn, Ph.D.

    Chief of Medical Physics, Clinical Physicist, Assistant Professor

    Chief of Medical Physics, Clinical Physicist, Assistant Professor

     


    Education/Training

    Institution and LocationDegreeDateField of Study
    University of Louisville, Brown Cancer Center6/2012Medical Physics Residency Program
    Georgia Institute of TechnologyPh.D.8/2009Nuclear Engineering
    Georgia Institute of TechnologyM.S.12/2006Medical Physics
    Georgia Institute of TechnologyB.S.8/2004Biomedical Engineering

    Positions and Honors

    Positions and EmploymentDate

    Chief of Physics
    Department of Radiation Oncology
    University of Louisville School of Medicine
    Louisville, KY

    5/2021 - Present

    Assistant Professor
    Department of Radiation Oncology
    University of Louisville School of Medicine
    Louisville, KY

    7/2017 - Present

    Clinical Medical Physicist
    Department of Radiation Oncology
    University of Louisville School of Medicine
    Louisville, KY     

    8/2012 - 7/2017

    Other Experience and Professional Memberships

    Honors

    • 8/2005 7/2008-National Science Foundation Fellow

    Selected peer-reviewed publications (in chronological order).

    1. Sowards, K., Swanson, C., Blackburn, M.,and Dragun, A., “A Dosimetric Analysis of the Fieldin Field Technique for the Treatment of Breast Cancer: Can Such a Low Dose as Those Used in the Field in Field Technique Actually be Delivered as Planned on the Planning System,” ASTRO Annual Meeting, Miami, Florida, October 2 6, 2011.
    2. Harkenrider, M., James, J., Blackburn, M., Bertke, M., and Spanos, W., “VMAT vs Tomotherapy: Which is Better for the Treatment of Locally Advanced Oropharyngeal Carcinoma?. Oncology, April 2012, 26(4) supplement1:73.
    3. Satterfield, M.,Rahnema, F., Zhang, D., and Fox, T.,“Evaluation of a Heterogeneous Coarse Mesh Photon Transport Method Using a Simplified Lung Model,” M&C + SNA 2007: Joint International Topical Meeting on Mathematics & Computations and Supercomputing in Nuclear Applications, Monterey, California, April 15 19, 2007.
    4. Satterfield, M.,Zhang, D., Rahnema, F., and Fox, T., “Extension of the Coarse-Mesh Transport Method to Medical Physics,” The American Nuclear Society’s 14thBiennial Topical Meeting of the Radiation Protection Shielding Division, Carlsbad,New Mexico, April 2-6, 2006.
    5. Satterfield, M., Forget, B., Rahnema, F., Fox, T., and Wang, C., “Application of a Heterogeneous Coarse-Mesh Transport Method to a Radiation Therapy Benchmark Problem,” AAPM Annual Meeting, Seattle, Washington, July 24 28, 2005.

    Christine Swanson, Ph.D.

    Clinical Physicist, Assistant Professor & Medical Physics Residency Director

    Clinical Physicist, Assistant Professor & Medical Physics Residency Director

     


    Education/Training

    Institution and LocationDegreeDateField of Study

    Transylvania University, Lexington, KY

    B.A.2005-2009Physics; Summa cum Laude

    University of Kentucky, Lexington, KY

    M.S.2009-2011Radiation Sciences

    University of Louisville, Louisville, KY

    2010-2012

    Residency in Radiation Physics

    University of Louisville, Louisville, KY

    Ph.D.2011-2019

    Public Health- Specialization in Health Management and Policy; Thesis Title: “An Evaluation of the Supply and Demand of the Radiation Oncology Medical Physicists in the United States”

    Positions and Honors

    Positions and EmploymentDate
    Assistant Professor
    Department of Radiation Oncology
    Brown Cancer Center
    University of Louisville
    School of Medicine, Louisville, KY
    March 2022 – Present

    Regional Chief of Physics 
    Department of Radiation Oncology
    Baptist Health Louisville
    Louisville, Kentucky

    December 2019 - December 2021

    Clinical Physicist
    Department of Radiation Oncology
    Baptist Health Louisville
    Louisville, Kentucky

    December 2013 - December 2019

    Clinical Physicist
    Department of Radiation Oncology
    Baptist Health Louisville
    Louisville, Kentucky

    October 2012 - December 2013

    Diagnostic Physicist Assistant
    Bluegrass Physics
    Lexington, Kentucky

    May 2009 - May 2011

    AAPM Summer Fellow 
    University of Kentucky
    Lexington, Kentucky

    Summer 2008

    Other Experience and Professional Memberships

    PROFESSIONAL SOCIETIES

    • Member of American Association of Physicists in Medicine  (2009 – Present)

    •  Member of AAPM Workforce Committee (2012 - Present)

    • Member of AAPM Therapy Demand and Supply Projection Workgroup  (2019 - Present)

    • Member of American Brachytherapy Society  (2011 - 2015, 2021 - Present)

    • Member of American Society of Therapeutic Radiation Oncology (2011 - 2015, 2021 - Present)

    • Member of the Health Physics Society  (2009 - 2015)

    Honors & Awards

    • President’s Scholarship, Transylvania University, 2005

    • Transylvania Scholarship, Transylvania University, 2007

    • Cralle Fellowship, University of Kentucky, 2009

    • Daniel Reedy Quality Achievement, University of Kentucky, 2009

    Selected peer-reviewed publications (in chronological order).

    1. Newhauser, W, Pitcher, G, Swanson, C, Armato, S, Al-Hallaq, H. “Interviewing for Residency Positions While Completing a Graduate Degree: Considerations for Graduate Students, Mentors, and Program Directors.” Journal of Applied Clinical Medical Physics, ID: ACM213700.  2022.

    2.  Chen, E, Mills, M, Antolak, J, Buzurovic, I, Dezarnm, W, Khan, F, Kirkby, C, Parker, B, Palicki, T, Zhong, S, Swanson, C, Tarver, R, Thomadsen, B, White, S, Wingreen, N, Zhou, S. “The Current State, Future Supply and Demand of Therapy Physicists- A Special Report of the 2020 AAPM Therapy Physicist Workforce Survey Results.” AAPM 2021

    3. Swanson, CM, Mills, M, “Future Trends in Demand and Supply for Radiation Oncology Physicists” Presentation AAPM ORVC Chapter Meeting, Cincinnati, OH November 2018

    4. Swanson, CM, Mills, M, “Future Trends in Demand and Supply for Radiation Oncology Physicists- 2018 Revision” Presentation at AAPM Annual Meeting, Nashville, TN July 2018

    5. James, JA, Lynch, B, Swanson, CM, Wang, B, Dunalp, NE. “Quantification of PTV Margin When Using Robotic Radiosurgery System to Treat Lung Tumors With Spine Tracking.” Practical Radiation Oncology. November 2014.

    6. Ram, N, Shaughnessy, J, Silverman, C, Bumpous, J, Potts, K, Redman, R, Cash, E, Swanson, C,Wilson, L, Dunlap, N.The relationship between patterns of failure and human papilloma virus (HPV) status for squamous cell carcinoma of the oropharynx after definitive chemoradiotherapy: what role does elective nodal irradiation play?Journal of Radiation Oncology (2014): 1-7 , November 22, 2014

    7. Hogue, C, Blackburn, M, Swanson, C, Lynch, B, Wang,B, El-Ghamry,M, “Optimum Frequency of Cone Beam Computed Tomography (CBCT) for Intact Prostate IMRT” Presentation ASTRO Annual Meeting, San Francisco, CA September 2014

    8. James, JA,  Swanson, CM, Lynch, B,Wang, B, Dunlap, NE. “Quantification of PTV Margin when Using Robotic Radiosurgery System to Treat Lung Tumors With Spine Tracking.” Presentation ASTRO Annual Meeting, San Francisco, CA September 2014.

    9. Sowards, K., Swanson, C., Blackburn, M., and Dragun, A., “A Dosimetric Analysis of the Field In Field Technique for the Treatment of Breast Cancer: Can Such a Low Dose as Those Used in the Field in Field Technique Actually be Delivered as Planned on the Planning System,” Presentation ASTRO Annual Meeting, Miami, Florida, October 2 – 6, 2011.

    10. Meigooni AS, Luerman CM, Sowards KT. “Evaluation of the dose distribution for prostate implants using various 125I and 103Pd sources.”  Medical Physics. 2009 April;36(4):1452-8.  

    11. Meigooni, A.S., Luerman, C.M., Pérez-Calatayud, J., Ballester, F., Rivard, M.J., Sowards, K.T., Zehtabian, M., & Walmsley, J.J. (2009). SU‐FF‐T‐15: Comparison of Various Monte Carlo Codes for Brachytherapy Source Dosimetry. Medical Physics, 36, 2522-2522.

    12. Mills, M, Swanson, CM, “Medical Dosimetry Workforce Study.” Report for the American Association of Medical Dosimetrists, Published online July 2021. Presented at AAMD Annual Meeting 2021.

    13. Consulting Panel Member for the Report “The Abt Study of Medical Physicist Work Values for Radiation Oncology Physics Services: Round IV”, Prepared for the AAPM, June 2015

    David L. Wilson, M.S.

    Clinical Physicist, Assistant Professor

    Assistant Professor

     


    Education/Training

    Institution and LocationDegreeDateField of Study
    Nucletron Corporation, Columbia, MDJanuary, 1990High Dose Rate Brachytherapy

    M.D. Anderson Hospital, Houston, Texas

    July, 1982External Beam Dosimetry—Principles and Calibrations
    External Beam, Interstitial and Intracavitary Dosimetry—Principles and Calibrations

    University of Kentucky, Lexington, Kentucky

    M.S.1978Physics

    Georgia Institute of Technology, Atlanta, Georgia

    B.S.1975Physics

    Positions and Honors

    Positions and EmploymentDate
    Assistant Professor
    Department of Radiation Oncology
    Brown Cancer Center
    University of Louisville
    School of Medicine, Louisville, KY
    March 2002 – Present

    Clinical Physicist
    Department of Radiation Oncology
    Brown Cancer Center
    University of Louisville

    Louisville, Kentucky
    March, 1985 – February 2002

    Junior Clinical Physicist/Dosimetrist
    Department of Radiation Oncology
    Brown Cancer Center
    University of Louisville
    Louisville, Kentucky

    April, 1982 - March, 1985

    Instructor, Division of Radiologic Technology
    School of Allied Health
    University of Louisville
    Louisville, Kentucky

    January, 1984 – May 1984

    Graduate Teaching Assistant, Physics Department
    University of Kentucky
    Lexington, Kentucky

    September, 1976 – May, 1978

    Explosives and Blasting Inspector/Instructor
    Kentucky Department of Mines and Minerals
    Lexington, Kentucky

    February, 1982 – April, 1982

     Assistant Process Physicist
    Brown and Williamson Tobacco Laboratory

    July, 1978 – August, 1981

    Other Experience and Professional Memberships

    CERTIFICATIONS

    • Board Certified in Radiation Therapy Physics by the American Board of Radiology, June, 1986.
    • Board Certified in Radiation Oncology Physics by the American Board of Medical Physics, January, 1992.

    PROFESSIONAL SOCIETIES

    • Full Member, American Association of Physicists in Medicine (1985 - Present)
    • Member, Bluegrass Chapter of the Health Physics Society (1983 - Present)
    • Full Member,  American Society for Radiation Oncology (2010 – Present)

    Honors

    • The Gold Apple Award for Excellence in Teaching, UT M.D. Anderson Cancer Center, 1990
    • Fellow, Royal College of Physicians, 1997
    • ACGME Parker J. Palmer Courage to Teach Award, 2001
    • Fellow, American College of Radiology, 2001
    • Teacher of the Year Award, The Association of Residents in Radiation Oncology, 2001
    • 2008 Patient Golden Apple Award, M.D. Anderson Cancer Center, 2008
    • The Julie and Ben Rogers Award for Excellence in Patient Care: Finalist, 2009

    Selected peer-reviewed publications (in chronological order).

    1. Sharma, S.C., Wilson, D.L., and Jose, B.:  Variation of output with atmospheric pressure and ambient temperature for Therac-20 linear accelerator.  Medical Physics 10:15, 712, 1983.
    2. Sharma, S.C., Wilson, D.L. and Jose, B.:  Iridium seed implantation procedures and safety guidelines.  AAMD Journal VIII:4, 1983.
    3. Sharma, S.C., Wilson, D.L. and Jose, B.:  Dosimetry of small fields for Therac-20 electron beams.  Medical Physics 11:5, 697-702, September/October 1984.
    4. Sharma, S.C., Wilson, D.L. and Jose, B.:  Radioactive cesium implantation procedures and safety guidelines.  AAMD Journal IX:3, 14-18, 1984.
    5. Dodd, D.T., George, D.I., Farman, A.G., Sharma, S.C. and Wilson, D.L.:  Backscatter radiation from restorative materials during Co-60 therapy, Journal of Oral Medicine, Vol. 40:2, 72-75, 100, 1985.
    6. Farman, A.G., Sharma, S.C., George, D.I., Wilson, D.L., Dodd, D., Figa, Robert, Haskell, Bruce:  Backscattering from dental restorations and splint materials during therapeutic radiation.  Radiology, 156:523-526, 1985.
    7. Sharma, S.C., and Wilson, D.L.:  Depth dose characteristics of elongated fields for electron beams from a 20 MeV accelerator.  Medical Physics, 12(4):July/August, 1985.
    8. Shorton, D.L., Farman, A.G., George, D.I., Sharma, S., and Wilson, D.:  Radiation exposure to critical structures during transfacial and transcranial TMJ radiography.   Dentomaxillofacial Radiology, 14:93-96, 1985.
    9. Wilson, D.L., Sharma, S.C., Jose, B., and Lindberg, R.D.:  An intracavitary cone system for electron beam therapy using Therac-20 linear accelerator.  Int. J. of Radiation Oncology/Biology, Physics, 12:1007-1011, 1986.
    10.  Sharma, S.C. and Wilson, David L.:  Dosimetric study of total skin irradiation with a scanning beam electron accelerator.  Medical Physics 14(3), May/June, 1987.

    11. B. Olipauram, Jose, M.D.; James L. Bailen, M.D.; Frederick H. Albrink, M.D.; Greg S. Steinbock, M.D.; Mark S. Cornett, M.D.; David C. Benson, M.D.; William K. Schmied, M.D.; Richard N. Medley, M.D.; William J. Spanos, M.D.; Kristie J. Paris, M.D., Paul D. Koerner, M.D.; Richard A Gatenby, Ph.D., David L. Wilson, M.S.; Richard Meyer, M.S.: Brachytherapy in Early Prostate Cancer--Early Experience.  Kentucky Medical Association Journal July 1999/Vol. 97, pgs. 12-16.

    Keith Sowards, M.S.

    Clinical Physicist, Assistant Professor

    Clinical Physicist, Assistant Professor

     


    Education/Training

    Institution and LocationDegreeDateField of Study
    University of KentuckyM.S.1999Health Physics
    University of KentuckyB.S.1995Physics

    Positions and Honors

    Positions and EmploymentDate

    Clinical Physicist
    Department of Radiation Oncology
    University of Louisville
    Louisville, KY

    August 2002 – Present

     

    Selected peer-reviewed publications (in chronological order)

    1. A.S. Meigooni, K. Sowards, M. Soldano:  Dosimetric Characteristics of the InterSource 103Palladium    Brachytherapy Source. Medical Physics 27(5), 1093-1100 (2000).
    2. C. Popescu, J. Wise, K. Sowards, A.S. Meigooni, and G. S. Ibbott:  Dosimetric Characteristics of the PharmaSeed TM Model BT-125-1 Source. Medical Physics 27(9), 2174-2281 (2000).
    3. Ali S. Meigooni, K. Sowards, D. Gearheart:  Experimental Determination of Dosimetric Characteristics of Best 125I Brachytherapy Source. Medical Physics 27(9), 2168-2173 (2000).
    4. D. Gearheart, A. Drogin, K. Sowards, A.S. Meigooni, and G.S. Ibbott:  Dosimetric Characteristics of a New 125I Brachytherapy Source. Medical Physics 27(10), 2278-2285 (2000).
    5. A.S. Meigooni, S.A. Dini, K. Sowards, J.L. Hayes, and A. Al-Otoom:  Experimental Determination of the TG-43 Dosimetric Characteristics of EchoSeed™ Model (6733 Brachytherapy Source. Medical Physics 29(6), 939-942 (2002).
    6. A. Meigooni, K. Sowards, G. Myron:  Evaluation of the QZ Veridose Patient Monitoring Phantom. Medical Dosimetry Journal 29:49-54 (2003).
    7. A. Meigooni, G. Myron, K. Sowards:  Evaluation of the Veridose Invivo Dosimetry System. Medical Dosimetry 27:29-36 (2002).
    8. A.S. Meigooni, M.M. Yoe-Sein, A.Y., Al-Otoom, and K.T. Sowards:  Determination of the Dosimetric Characteristics of InterSource 125Iodine Brachytherapy Source. Applied Rad & Isotopes 56:589-599 (2002).
    9. Ali S. Meigooni, Joshua Hayes, Hualin Zhang, and Keith Sowards:  Experimental Determination of IsoAid ADVANTAGE™ 125I Brachytherapy Source. Medical Physics 29(9):2152-2158 (2002).
    10. A.S. Meigooni, Z. Bharucha, M. Yoe-Sein, and K.T. Sowards:  Dosimetric characteristics of the Best® double-wall 103Pd brachytherapy source. Med Phys 28(12):2568-2575 (2001).
    11. K.T. Sowards, A.S. Meigooni:  A Monte Carlo evaluation of the dosimetric characteristics of the Best ® Model 2301 125I Brachytherapy Source. Applied Radiation and Isotopes 57:327-333 (2002).
    12. K.T. Sowards, A.S. Meigooni:  A Monte Carlo evaluation of the dosimetric characteristics of the Amersham model 6733 125I brachytherapy source. Brachytherapy Vol. 1(4):227-232 (2002).
    13. Erratum: “Experimental and theoretical determination of dosimetric characteristics of IsoAid ADVANTAGE™ 125I brachytherapy source” [Med. Phys. 29, 2152–2158 (2002)], Med. Phys. 30, 279 (2003).
    14. K.T. Sowards: Monte Carlo Dosimetric Characterization of the IsoAid ADVANTAGETM 103Pd Brachytherapy Source. Journal of the American College of Medical Physics, Vol 8, No 2, (2007).
    15. K.T. Sowards, C.M. Luerman, A.S. Meigooni:  Evaluation of the dose distribution for prostate implants using various 125I and 103Pd sources. Med Phys 36(4):1452-1458 (2009).

    Joshua James, M.S.

    Clinical Physicist, Assistant Professor

    Clinical Physicist, Assistant Professor 


    Education/Training

    Institution and LocationDegreeDateField of Study
    University of WisconsinM.S.2005Medical Physics
    Western Kentucky UniversityB.S.8/2003Physics

    Positions and Honors

    Positions and EmploymentDate
    Clinical Physicist
    Department of Radiation Oncology
    University of Louisville School of Medicine
    Louisville, KY
    June 2005-Present

    Other Experience and Professional Memberships

    PROFESSIONAL SOCIETIES

    • American Board of Radiology Radiologic Physics Part III, June 2009
    • American Society for Radiation Oncology, member since 2009
    • American Board of Radiology Radiologic Physics Part II, Aug 2008
    • American College of Medical Physics, member since April 2008
    • American Board of Radiology Radiologic Physics Part I, Aug 2005
    • American Association of Physicists in Medicine, member since Jan 2004
    • Sigma Pi Sigma (physics honor society), member since spring 2002

    Honors

    • RSNA/AAPM Fellowship for Graduate Study in Medical Physics, 2003 2005
    • Ogden Trustees’ Award, Western Kentucky University, May 2003
    • Scholar of the Ogden College of Science and Engineering, Western Kentucky University, May 2003
    • AAPM Summer Undergraduate Fellowship, 2001
    • Award ofExcellence Scholarship, Western Kentucky University, 1999 2003

    Selected peer-reviewed publications (in chronological order)

    1. J James, A Cetnar, N Dunlap, C Huffaker, V Nguyen, M Potts, B Wang.  “Technical Note: Validation and implementation of a wireless transponder tracking system for gated stereotactic ablative radiotherapy of the liver,” Medical Physics. 43:6 (June 2016) 2794-2801.

    2. V Nguyen, D Ellerbusch, A Cetnar, J James, B Wang.  “Implementation of an in-house visual feedback system for motion management during radiation therapy,”  J Appl Clin Med Phys. 17:1 (Jan 2016) 5817

    3. A Cetnar, J James, B Wang.  “Commissioning of a motion system to investigate dosimetric consequences due to variability of respiratory waveforms,”  J Appl Clin Med Phys. 17:1 (Jan 2016) 5921

    4. J James, C Swanson, B Lynch, B Wang, N Dunlap.  “Quantification of PTV margin when using a robotic radiosurgery system to treat lung tumors with spine tracking,”  Practical Radiation Oncology. 5:4 (Jul-Aug 2015) e337-e343.

    5. K McCullough, J James, M McCullough, A Cetnar, B Wang.  “Site-Specific tolerance tables and indexing device to improve patient setup variability,” J Appl Clin Med Phys. 16:3 (May 2015) 5230

    6. V Sarkar, B Wang, H Zhao, B Lynch, J James, K McCullough, B Saltar.  “Percent depth-dose distribution discrepancies from very small volume ion chambers,”  J Appl Clin Med Phys. 16:2 ( March 2015) 432-442

    7. C Cheng, L Zhao, M Wolanski, Q Zhao, J James, K Dikeman, M Mills, M Li, S Srivastave, XQ Lu, I Das. “Comparison of Tissue Characterization Curves for Different CT Scanners: Implication in Proton Therapy Treatment Planning.” Translational Cancer Research. 1:4 (December 2012) 236-246

    8. JD Fenwick, WA Tome, HA Jaradat, SK Hui, JA James, JP Balog, CN DeSouza, DB Lucas, GH Olivera, TR Mackie, BR Paliwal.  “Quality Assurance of a Helical Tomotherapy Machine.”  Phys. Med. Biol. 49 (2004) 2933-2953

    9. MW Kissick, J Fenwick, JA James, R Jeraj, JM Kapatoes, H Keller, TR Mackie, G Olivera, ET Soisson. “The Helical Tomotherapy Thread Effect.” Medical Physics. 32:5 (May 2005) 1414-14234.
    10. SA Boswell, R Jeraj, KJ Ruchala, GH Olivera, HA Jaradat, JA James, A Gutierrez, D Pearson, G Frank, TR Mackie. “A Novel Method to Correct for Pitch and Yaw Patient Setup Errors in Helical Tomotherapy.” Medical Physics. 32:6 (June 2005) 1630-1639.

    Silva_New_7.2022

    Silva_New_7.2022
    Full-size image:64 KB | View imageViewDownload imageDownload

    DeAnna O'Connell

    Program Coordinator

    JPEG image icon O'Connell, DeAnna_9985.jpg — JPEG image, 2.10 MB (2201177 bytes)

    DeAnna O'Connell

    Program Coordinator

    DeAnna serves as the Program Coordinator for both the Medical Physics & Radiation Oncology Residency programs. In addition, DeAnna also serves on the Board of Directors of the Association of Radiation Oncology Program Coordinators as the Chair of the Steering Committee. She also serves on the Quality and Patient Safety Committee with the University, representing Program Coordinators. Her personal interests include yoga, camping, hiking, and she is an avid gardener.


    N_2022

    N_2022
    Full-size image:114 KB | View imageViewDownload imageDownload

    D_2022

    D_2022
    Full-size image:2.10 MB | View imageViewDownload imageDownload

    D_2022

    D_2022
    Full-size image:2.10 MB | View imageViewDownload imageDownload

    D_2022

    D_2022
    Full-size image:2.10 MB | View imageViewDownload imageDownload

    D_2022-2

    D_2022-2
    Full-size image:3.99 MB | View imageViewDownload imageDownload